BDC Fund Investments (Fund-of-Funds) β Full Portfolio
30 tracked investments Β· listed companies and verified rows first
Co-investorsBDC Industrial Innovation Venture FundEmmertechInBC Investment Corp.Stray Dog CapitalUCeed FundsVoyager Capital+1 more
Vancouver
Anson Kung(Executive Officer)Matthew Anderson(Executive Officer, Director)Jessica Yip(Executive Officer, Director)
Co-investorsBDC Industrial Innovation Venture FundFundersClub
Agilicus provides a cloud-native Zero Trust Network Access platform that gives users secure, client-less and VPN-free connectivity to resources such as web applications, remote desktops, databases, and industrial control systems (PLCs, SCADA, HMIs, building management systems).
Cloud ComputingCybersecurityIoT
Co-investorsMistral Venture Partners
Co-investorsCreative Destruction Lab (CDL)
Develops proprietary pet food formulations using sustainable novel ingredients such as insects, fungi, and algae to replace animal proteins, aiming for hypoallergenic, nutrient-dense, and environmentally sustainable products.
Co-investorsBDC Thrive Lab for WomenSheBoot
alterBiota develops green materials and energy technologies, including bio-graphene concrete admixtures and low-carbon concrete solutions, along with related R&D and testing services.
Circular EconomyCleantechClimate TechNew MaterialsEdwardsville, CA
Mark Masotti(CEO and Co-Founder)
Co-investorsBDC Climate Tech Fund II
AlumaPower develops firm, dispatchable power technology aimed at addressing shortfalls in reliable 24/7 electricity for demand from AI data centers, re-industrialization, and electrification.
CleantechClimate TechEnergyHardwareSarnia, CA
Paul Andrew Simpson(Director)Geoffrey Richard Steven Godwin(Director)Geoff Thomas Sheerin(Executive Officer)Rob Alexander(Co-Founder & CEO)inHenk VandenEnde(Co-Founder & EVP, Business Development)inGeoff Sheerin(Inventor, Co-Founder & CTO)
Co-investorsCreative Destruction Lab (CDL)Starbridge Venture Capital Llc
Canadian healthcare VC firm investing across all segments of precision medicine, including therapeutics, medical technologies, and AI-enabled precision medicine, healthcare IT and services.
Co-investorsInBC Investment Corp.
Amplitude VC creates, builds, and grows companies specializing in precision medicine to transform patient outcomes.
BiotechDigital HealthMedical DevicesMontreal, CA
Co-investorsRBCx
Auvik is a cloud-based AI-powered IT operations platform that helps managed service providers and IT departments monitor and manage networks, SaaS applications, and endpoints.
AI & Machine LearningCloud ComputingEnterprise SoftwareIoTWaterloo, CA
Alex HoffMarc MorinDavid YachDouglas Murray(Chief Executive Officer)
Co-investorsCeltic House Asia PartnersCeltic House Venture PartnersGolub GrowthOpenView Venture PartnersRho Capital PartnersRho Ventures+1 more
Canadian private venture capital firm investing at the commercialization and growth stage in industrial bioproducts, nutraceutical ingredients, and food technology; BDC is invested in Avrio Ventures I and Avrio Ventures III.
Axonify offers an AI-powered frontline enablement platform that combines microlearning, guided execution, and performance insights to help frontline employees train, apply knowledge, and perform on the job.
AI & Machine LearningEdTechEnterprise SoftwareHR TechSaaS
Co-investorsBridgescale PartnersHarmony PartnersJMI EquityWaterloo Accelerator Centre
Business Development Bank of Canada (BDC) provides financing, advisory services, and educational resources to Canadian entrepreneurs and small and medium-sized businesses.
Fintech
Co-investorsBDC Climate Tech Fund IIBDC Growth Venture FundBDC Industrial Innovation Venture FundBDC Life Sciences Venture FundBDC Seed Venture FundBDC Sustainability Venture Fund+8 more
Quadient AP (formerly Beanworks) is an accounts payable automation platform that captures invoices, automates approvals and validation, and manages supplier payments and expenses.
AI & Machine LearningFintechSaaS
Co-investorsPallasite Ventures
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.

